14-isoquinolin-6-yl-9-oxa-14-azapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene
C27H16N2O — CID 118502666
Data last refreshed: (MolForge compound catalog, from PubChem)
About 14-isoquinolin-6-yl-9-oxa-14-azapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene
14-isoquinolin-6-yl-9-oxa-14-azapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene (PubChem CID 118502666) has the molecular formula C27H16N2O and a molecular weight of 384.44 g/mol. Its IUPAC name is 14-isoquinolin-6-yl-9-oxa-14-azapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene.
Molecular Properties
| Compound Name | 14-isoquinolin-6-yl-9-oxa-14-azapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene |
|---|---|
| PubChem CID | 118502666 |
| Molecular Formula | C27H16N2O |
| Molecular Weight | 384.44 g/mol |
| Exact Mass | 384.13 |
| IUPAC Name | 14-isoquinolin-6-yl-9-oxa-14-azapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene |
| SMILES | c1ccc2c(c1)oc1ccc3c(c4ccccc4n3-c3ccc4cnccc4c3)c12 |
| InChI | InChI=1S/C27H16N2O/c1-3-7-22-20(5-1)26-23(11-12-25-27(26)21-6-2-4-8-24(21)30-25)29(22)19-10-9-18-16-28-14-13-17(18)15-19/h1-16H |
| InChIKey | TZGBISSUOZAZLF-UHFFFAOYSA-N |
| XLogP | 7.23 |
| TPSA | 30.96 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 384.44 |
| LogP ≤ 5 | 7.23 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118502666 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.